Evaluating clinical and public health interventions: A practical guide to study design and statistics

Evaluating Clinical and Public Health Interventions: A Practical Guide to Study Design and Statistics

Volumn , Issue , 2010, Pages 1-163

  Katz, Mitchell H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925150791     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511712074     Document Type: Book

References (178)

1. Katz, M. H. “Interventions to increase interventions are needed.” J. Publ. Health Mgt. Pract.14 (2008): 224-7.
2. Millward, L., Kelly, M., and Nutbeam, D. Public Health Intervention Research: The Evidence. London: Health Development Agency, 2003. www.nice.org.uk/niceMedia/documents/pubhealth.interventon.pdf. Accessed 3 March, 2008.
3. Farley, T. A., Meriwether, R. A., Baker, E. T., Watkins, L. T., Johnson, C. C., and Webber, L. S. “Safe play spaces to promote physical activity in inner-city children: results from a pilot study of an environmental intervention.” Am. J. Public Health97 (2007): 1625-31.
4. Hu, T., Sung, H. Y., and Keeler, T. E. “Reducing cigarette consumption in California: tobacco taxes vs an anti-smoking media campaign.” Am. J. Public Health85 (1995): 1218-22.
5. Costello, E. J., Compton, S. N., Keeler, G., and Angold, A. “Relationships between poverty and psychopathology: a natural experiment.” JAMA290 (2003): 2023-9.
6. Berk, R. A. and Rossi, P. H. Thinking about Program Evaluation 2. Th ousand Oaks: Sage Publications, 1999
7. Shadish, W. R. “The common threads in programevaluation.” Prev Chronic Dis391 (2006): A03 at http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16356356.
8. Pronovost, P., Needham, D., Berenholtz, S., et al. “An intervention to decrease catheter-related bloodstream infections in the ICU.” N. Engl. J. Med. 355 (2006): 2725-32.
9. Holman, W. L., Allman, R. M., Sansom, M., et al. “Alabama coronary artery bypass graft ing project: results of a statewide quality improvement initiative.” JAMA 285 (2001): 3003-10.
10. Moskowitz, J. M., Lin, Z., and Hudes, E. S. “The impact of workplace smoking ordinances in California on smoking cessation.” Am. J. Public Health90 (2000): 757-61.
11. Pell, J. P., Haw, S., Cobbe, S., et al. “Smoke-free legislation and hospitalizations for acute coronary syndrome.” N. Engl. J. Med. 359 (2008): 482-91.
12. Loomis, D., Marshall, S. W., Wolf, S. H., Runyan, C. W., and Butts, J. D. “Eff ectiveness of safety measures recommended for prevention of workplace homicide.” JAMA287 (2002): 1011-7.
13. Hawkins, J. D., Catalano, R. F., Kosterman, R., Abbott, R., and Hill, K. G. “Preventing adolescent health-risk behaviors by strengthening protection during childhood.” Arch. Pediatr. Adolesc. Med. 153 (1999): 226-34.
14. Berk, R. A. and Rossi, P. H. Thinking about Program Evaluation 2. Sage: Th ousand Oaks, 1999.
15. Bakris, G. L. and Berkwits, M. “Trials that matter: The effect of a fi xed-dose combination of an angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.” Ann. Intern. Med.148 (2008): 400-1.
16. Patel, A., ADVANCE Collaborative Group. “Eff ects of a fi xed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomized controlled trial.” Lancet 370 (2007): 829-40.
17. M anson, J. E. and Martin, K. A. “Postmenopausal hormone-replacement therapy.” N. Engl. J. Med.345 (2001): 34-40.
18. Grodstein, F., Clarkson, T. B., and Manson, J. E. “Understanding the divergent data on postmenopausal hormone therapy.” N. Engl. J. Med.348 (2003): 645-50.
19. Writing Group for the Women's Health Initiative Investigators. “Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.” JAMA288 (2002): 321-33.
20. Glasgow, R. E., Lichtenstein, E., and Marcus, A. C. “Why don’t we see more translation of health promotion research to practice? Rethinking the effi cacy-to-eff ectiveness transition.” Am. J. PublicHealth 93 (2003): 1261-7.
21. Wolchik, S. A., Sandler, I. N., Millsap, R. E., et al. “Six-year follow-up of preventive interventions for children of divorce.” JAMA 288 (2002): 1874-81.
22. CDC. “Framework for program evaluation in public health.” MMWR 48 (1999) (RR11): 1-40. www.cdc.gov/mmwr/preview/mmwrhtml/rr4811a1.htm.
23. Stein, B. D., Jaycox, L. H., Kataoka, S. H., et al. “A mental health intervention for schoolchildren exposed to violence: a randomized controlled trial.” JAMA 290 (2003): 603-11.
24. Katz, M. H. Study Design and Statistical Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge University Press,2006: pp. 18-19.
25. Venstrom, J. M., McBride, M. A., Rother, K. I., Hirshberg, B., Orchard, T. J., and Harlan, D. M. “Survival after pancreas transplantion in patients with diabetes and preserved kidney function.” JAMA 290 (2003): 2817-23.
26. Kieffer, E. C., Palmisano, G., et al. “Racial and ethnic approaches to community health (Reach) Detroit partnership: improving diabetes-related outcomes among African-American and Latino adults.” Am. J. Public Health 95 (2005): 1552-60.
27. Golden, J. A., Chernoff, D., Hollander, H., Feigal, D., and Conte, J. E. “Prevention of Pneumocystis carinii pneumonia by inhaled pentamadine.” Lancet (1989): 654-7.
28. Concato, J., Wells, C. K., and Horwitz, R. I., et al. “The eff ectiveness of screening for prostate cancer: a nested case-control study.” Arch. Intern. Med. 166 (2006): 38-43.
29. Concato, J., Wells, C. K., and Horwitz, R. I., et al. “The effectiveness of screening for prostate cancer: a nested case-control study.” Arch. Intern. Med. 166 (2006): 38-43.
30. Grodstein, F., Martinez, M. E., Platz, E., et al. “Postmenopausal hormone use and risk for colorectal cancer and adenoma.” Ann. Intern. Med. 128 (1998): 705-12.
31. Haberer, J. E., Garrett, B., and Baker, L. C. “Does Medicaid managed care aff ect access to care for the uninsured?” Health Aff airs24 (2005): 1095-1105.
32. Shope, J. T., Molnar, L. J., Elliott, M. R., and Waller, P. F. “Graduated driver licensing in Michigan: early impact on motor vehicle crashes among 16-year-old drivers.” JAMA 286 (2001): 1593-8.
33. Morden, N. E., Zerzan, J., Rue, T. C., et al. “Medicaid prior authorization and controlled-release oxycodone.” Med. Care 16 (2008): 573-80.
34. Hannan, E. L., Wu, C., Walford, G., et al. “Drug-eluting stents vs. coronaryartery bypass graft ing in multivessel coronary artery disease.” N. Engl. J. Med. 358 (2008): 331-41.
35. Wen, C. P., Tsai, S. P., and Chung W.-S. I. “A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity.” Ann. Intern.Med. 148 (2008): 258-67.
36. Grodstein, F., Martinez, M. E., Platz, E., et al. “Postmenopausal hormone use and risk for colorectal cancer and adenoma.” Ann. Intern. Med. 128 (1998): 705-12.
37. Lipscombe, L. L., Gomes, T., Levesque, L. E., Hux, J. E., Juurlink, D. N., and Alter, D. A. “Th iazolidinediones and cardiovascular outcomes in older patients with diabetes.” JAMA298 (2007): 2634-43.
38. O’Loughlin, J. L., Paradis, G., Gray-Donald, K., and Renaud, L. “The impact of a community-based heart disease prevention program in a low-income, inner-city neighborhood.” Am. J. Public Health 89 (1999); 1819-26.
39. Luepker, R. V., Murray, D. M., Jacobs, D. R., et al. “Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program.” Am. J. Public Health 84 (1994): 1383-93.
40. Kelsy, J. L., Whittemore, A. S., Evans, A. S., and Th ompson, W. D. Methods in Observational Epidemiology(2nd edition). Oxford: Oxford University Press, 1996: pp. 364-412.
41. Katz, M. H. Study Design and Statistical Analysis: A Practical Guide for Clinicia ns. Cambridge: Cambridge University Press, 2006: pp. 38-51.
42. Nadelman, R. B., Nowakowski, J., Fish, D., et al. “Prophylaxis with single-dose doxycycline for the prevention of Lyme disease aft er an ixodes scapularis tick bite.” N. Engl. J. Med. 345 (2001): 79-84.
43. Pletcher, M. J., Fernandez, A., May, T. A., et al. “Unintended consequences of a quality improvement program designed to improve treatment of alcohol withdrawal in hospitalized patients.” Jt. Comm. J. Qual. Patient Saf. 31 (2005): 148-157.
44. Chan, A. W., Hrobjartsson, A., Haahr, M. T., Gotzsche, P. C., and Altman, D. G. “Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.” JAMA291 (2004): 2457-65.
45. Friedman, L. M., Furberg, C. D., and DeMets, D. L. Fundamentals of Clinical Trials(3rd edition). New York: Springer, 1999: pp. 94-129.
46. Katz, M. H. Study Design and Statistical Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge UniversityPress: 1996: pp. 127-40.
47. Halpern, S. D., Karlawish J. H. T., and Berlin, J. A. “The continuing unethical conduct of underpowered clinical trials.” JAMA288 (2002): 358-62.
48. Miller, F. G. and Emanuel, E. “Quality-improvement research and informed consent.” N. Engl. J. Med.358 (2008): 765-7
49. Baily, M. A. “Harming through protection?” N. Engl. J. Med.358 (2008): 768-9.
50. Klassen, T. P., Wiebe, N., Russell, K., et al. “Abstracts of randomized controlled trials presented at the society for pediatric research meeting: an example of publication bias.” Arch. Pediatr. Adolesc.Med. 156 (2002): 474-9.
51. De Angelis, C., Drazen, J. M., Frizelle, F. A., et al. “Is this clinical trial fully registered?” A statement from the International Committee of Medical Journal Editors. www.icmje.org/clin_trialup.htm.
52. DiClemente, R. J. and Wingood, G. M. “A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women.” JAMA274 (1995): 1271-6.
53. Friedman, L. M., Furberg, C. D., and DeMets, D. L. Fundamentals of Clinical Trials(3rd edition). New York: Springer, 1999: pp. 43-6.
54. Connors, A. F., Speroff, T., Dawson, N. V., et al. “The eff ectiveness of right-heart catheterization in the initial care of criticallyill patients.” JAMA276 (1996): 889-97.
55. Sandham, J. D., Hull, R. D., Brant, R. F., et al. “A randomized, controlled trial of the use of pulmonary artery catheters in high-risk surgical patients.” N. Engl. J. Med. 348 (2003): 5-14.
56. Coats, A. J. “Clinical trials, treatment guidelines and real life”. Int. J. Cardiol.73 (2000): 205-7.
57. Kernan, W. N., Viscoli, C. M., Makuch, R. W., Brass, L. M., and Horwitz, R. I. “Stratified randomization for clinical trials.” J. Clin. Epidemiol., 52 (1999): 19-26.
58. Donner, A. and Klar, N. “Pitfalls of and controversies in cluster randomization trials.” Am. J. Public Health94 (2004): 416-22.
59. Shafer, M. B., Tebb, K. P., Pantell, R. H., et al. “Effect of a clinical practice improvement intervention on chlamydial screening among adolescent girls.” JAMA288 (2002): 2846-52.
60. O’Donnell, L. N., Doval, A. S., Duran, R., and O’Donnell, C. “Video-based sexually transmitted disease patient education: its impact on condom acquisition.” Am. J. Public Health85 (1995): 817-22.
61. Kiel, D. P., Magaziner, J., Zimmerman, S., et al. “Effi cacy of a hip protector to prevent hip fracture: the HIP PRO randomized controlled trial.” JAMA 298 (2007): 413-22.
62. Horng, S. and Miller, F. G. “Is placebo surgery unethical?” N. Engl. J. Med.347 (2002): 137-9.
63. Ellenberg, J. H. “Intent-to-treat analysis versus as-treated analysis.” Drug Info. J.30 (1996): 535-44. Available at www.diahome.org/content/abstract/1996/dj302616.pdf.
64. Weinstein, J. N., Tostson, T. D., Lurie, J. D., et al. “Surgical vs nonoperative treatment for lumbar disk herniation.” JAMA 296 (2006): 2441-50.
65. Raschke, R. A., Gollihare, B., Wunderlich, T. A., et al. “A computer alert system to prevent injury from adverse drug events.” JAMA 280 (1998): 1317-20.
66. Carleton, R. A., Lasater, T. M., Assaf, A. R., et al. “The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk.” Am. J. Public Health 85 (1995): 777-85.
67. Pell, J. P., Haw, S., Cobbe, S., et al. “Smoke-free legislation and hospitalizations for acute coronary syndrome.” N. Engl. J. Med. 359 (2008): 482-91.
68. Ray, W. A., Meredith, S., Th apa, P. B., Meador, K. G., Hall, K., and Murray, K. T. “Antipsychotics and the risk of sudden cardiac death.” Arch. Gen. Psychiatry58 (2001): 1161-7.
69. Go, A. S., Hylek, E. M., Chang, Y., et al. “Anticoagulation therapy for stroke prevention in atrial fi brillation: how well do randomized trials translate into clinical practice?” JAMA 290 (2003): 2685-92.
70. N ichol, K. L., Margolis, K. L., Wuorenma, J., and Sternberg, T. V. “The efficacy and cost eff ectiveness of vaccination against infl uenza among elderly persons living in the community.” N. Engl. J. Med.331 (1994): 778-84.
71. Salas, M., Hofman, A., and Stricker B.H. “Confounding by indication: an example of variation in the use of epidemiologic terminology.” Am. J. Epidemiol.149 (1999): 981-3.
72. Hak, E., Verheij T. J. M., Grobbee, D. E., Nichol, K. L., and Hoes, A. W. “Confounding by indication in non-experimental evaluation of vaccine eff ectiveness: the example of prevention of influenza complications.” J. Epidemiol. Community Health56 (2002): 951-5. www.jech.bmj.com
73. Grobbee, D. E. and Hoes, A. W. “Confounding and indication for treatment in evaluation of drug treatment for hypertension.” BMJ315 (1997): 1151-4. http://bmj.bmjjournals.com/cgi/content/full/315/7116/1151.
74. Sjostrom, L., Narbro, K., Sjostrom, C. D., et al. “Effects of bariatric surgery on mortality in Swedish obese subjects.” N. Engl. J. Med. 357 (2007): 741-52
75. Sjostrom, L., Lindroos, A., Peltonen, M., et al. “Lifestyle, diabetes, and cardiovascular risk factors 10 years aft er bariatric surgery.” N. Engl. J. Med.351 (2004): 2683-93.
76. Katz, M. H. Study Design and Statistical Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge University Press, 2006: pp. 116-9.
77. King, J. C., Stoddard, J. J., Gaglani, M. J., et al. “Eff ectiveness of school-based infl uenza vaccination.” N. Engl. J. Med. 355 (2006): 2523-32.
78. Katz, M. H. Study Design and Statistical Analysis: A Practical Guide for Clinician s. Cambridge: Cambridge University Press, 2006: pp. 35-6, 52-9.
79. Savoye, M., Shaw, M., Dziura, J., et al. “Eff ects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial.” JAMA 297 (2007): 2697-704.
80. Garfi nkel, M. S., Singhal, A., Katz, W. A., et al. “Yoga-based intervention for carpal tunnel syndrome: A randomized trial.” JAMA 280 (1998): 1601-3.
81. Taubert, D., Roesen, R., Lehmann, C., Jung, N., and Schomig, E. “Eff ects of low habitual cocoa intake on blood pressure and bioactive nitric oxide.” JAMA298 (2007): 49-60.
82. Holm, S. “A simple sequentially rejective multiple test procedure.” Scand. J. Stat.6 (1979): 65-70.
83. Belfort, R., Harrison, S. A., Brown, K., et al. “A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.” N. Engl. J. Med. 355 (2006): 2297-307.
84. Back, L., Poloheimo, M., Ylikoski, J. “Traditional tonsillectomy compared with bipolar radiofrequency thermal ablation tonsillectomy in adults.” Arch. Otolaryngol. Head Neck Surg.127 (2001): 1106-12.
85. Slifkin, R. T., Freeman, V. A., and Silberman, P. “Effect of the North Carolina State Children's Health Insurance Program on benefi ciary access to care.” Arch. Pediatr. Adolesc. Med.156 (2002): 1223-29.
86. Fagard, C., Oxenius, A., Gunthard, H., et al. “A prospective trial of structured treatment interruptions in human immunodefi ciency virus infection.” Arch. Intern. Med. 163 (2003): 1220-6.
87. Kieff er, E. C., Palmisano, G., et al. “Racial and ethnic approaches to community health (Reach) Detroit partnership: Improving diabetes-related outcomes among African American and Latino adults.” Am. J. Public Health. 95 (2005): 1552-60.
88. Jones, K. T., Gray, P., Whiteside, Y. O., et al. “Evaluation of an HIV prevention intervention adapted for black men who have sex with men.” Am. J. Public Health 98 (2008): 1043-50.
89. Katz, M. H. Study Design and Statistical Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge University Press, 2006:pp. 77-9.
90. Walter, H. J. and Vaughan, R. D. “AIDS risk reduction among a multiethnic sample of urban high school students.” JAMA270 (1993): 725-30.
91. Tan, K. L. “Decreased response to phototherapy for neonatal jaundice in breast-fed infants.” Arch. Pediatr. Adolesc. Med.152 (1998): 1187-90.
92. Glantz, S. A. Primer of Biostatistics (5Thedition). New York: McGraw-Hill, 2002: pp. 89-107.
93. Katz, M. H. Multivariable Analysis: A Practical Guide for Clinicians (2nd edition). Cambridge: Cambridge University Press: pp. 35-7.
94. Andersen, R. E., Waddan, T. A., Bartlett, S. J., Zemel, B., Verde, T. J., and Franckowiak, S. C. “Effects of lifestyle activity vs structured aerobic exercise on obese women: A randomized trial.” JAMA281 (1999): 335-40.
95. Lautenschlager, N. T., Cox, K. L., Flicker, L., et al. “Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease.” JAMA 300 (2008): 1027-37.
96. Twisk, J. W. R. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. Cambridge: Cambridge University Press, 2003: pp. 62-95
97. Diggle, P. J., Heagerty, P., Liang K.-Y., et al. Analysisof Longitudinal Data (2nd edition). Oxford: Oxford University Press, 2002: pp. 128-30, 138-40
98. Davis, C. S. Statistical Methods for the Analysis of Repeated Measurements. New York: Springer-Verlag, 2003: pp. 293, 295-313
99. Katz, M. H. Multivariable Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge University Press, 2006: pp. 164-71.
100. Kegeles, S. M., Hays, R. B., and Coates, T. J. “The Mpowerment project: A community-level HIV prevention intervention for young gay men.” Am. J. Public Health86 (1996): 1129-36.
101. Johnson, B. A., Rosenthal, N., Capece, J. A., et al. “Topiramate for treating alcohol dependence: A randomized controlled trial.” JAMA 298 (2007): 1641-51.
102. Katz, M. H. Study Design and Statistical Analysis: A Practical Guide for Clinician s. Cambridge: Cambridge University Press, 2006: pp. 61-4.
103. Snyder, C. and Anderson, G. “Do quality improvement organizations improve the quality of hospital care for Medicare benefi ciaries.” JAMA293 (2005): 2900-7.
104. Tseng C.-W., Brook, R. H., Keeler, E., Steers, W. N., and Mangione, C. M. “Cost-lowering strategies used by Medicare benefi ciaries who exceed drug benefit caps and have a gap in drug coverage.”JAMA 292 (2004): 952-60.
105. Katz, M. H. Study Design and Statistical Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge University Press, 1996: pp. 116-9.
106. Katz, M. H. Multivariable Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge University Press, 1996: pp. 158-78.
107. Berry, R. J., Li, Z., Erickson, J. D., et al. “Prevention of neural-tube defects with folic acid in China.” N. Engl. J. Med. 341 (1999): 1485-90.
108. Rubin, D. B. “Estimating causal eff ects from large data sets using propensity scores.” Ann. Intern. Med.127 (1997): 757-63.
109. D’Agostino, R. B. “Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.” Statist. Med.17 (1998): 2265-81.
110. Gum, P. A., Th amilarasan, M., Watanabe, J., Blackstone, E. H., and Lauer, M. S. “Aspirin use and allcause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis.” JAMA286 (2001): 1187-94.
111. Austin, P. C., Grootendorst, P., and Anderson, G. M. “A comparison of the ability of diff erent propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study.” Statist. Med.26 (2007): 734-53.
112. Rubin, D. B. “Estimating causal eff ects from large data sets using propensity scores.” Ann. Intern. Med.127 (1997): 757-63.
113. Katz, M. H. Multivariable Analysis: A Practical Guide for Clinicians(2nd edition). Cambridge: Cambridge University Press, 2006: p. 124.
114. Landrum, M. B. and Ayanian, J. Z. “Causal eff ect of ambulatory specialty care on mortality following myocardial infarction: A comparison of propensity score and instrumental variable analyses.” Health Serv. Outcomes Res. Methodol.2 (2001): 221-45.
115. Stukel, T. A., Fisher, E. S., Wennberg, D. E., Alter, D. A., Gottlieb, D. J., and Vermeulen, M. J. “Analysis of observational studies in the presence of treatment selection bias: Eff ects of invasive cardiac management on AMI survival using propensity score and instrument variable methods.” JAMA 297 (2007): 278-85.
116. Austin, P. C. “The performance of diff erent propensity score methods for estimating marginal odds ratios.” Statist. Med.26 (2007): 3078-94.
117. Wang, P. S., Schneeweiss, S., and Avorn, J. “Risk of death in elderly users of conventional vs. atypical antipsychotic medications.” N. Engl. J. Med.353 (2005): 2235-41.
118. Rubin, D. B. “Estimating causal eff ects from large data sets using propensity scores.” Ann. Intern. Med.127 (1997): 757-63.
119. Landrum, M. B. and Ayanian, J. Z. “Causal eff ect of ambulatory specialty care on mortality following myocardial infarction: A comparison of propensity score and instrumental variable analyses.” Health Serv. Outcomes Res. Methodol.2 (2001): 221-45.
120. Levy, M. M., Rapoport, J., Lemeshow, S., Chalfi n, D. B., Phillips, G., and Danis, M. “Association between critical care physician management and patient mortality in the intensive care unit.” Ann.Intern. Med. 148 (2008): 801-9.
121. McNiel, D. E. and Binder, R. L. “Eff ectiveness of a mental health court in reducing criminal recidivism and violence.” Am. J. Psychiatry64 (2007): 1395-403.
122. Lunceford, J. K. and Davidian, M. “Stratifi cation and weighting via the propensity score in estimation of causal treatment eff ects: A comparative study.” Statist. Med.23 (2004): 2937-60.
123. R ubin, D. N. “Using propensity scores to help design observational studies: Application to the tobacco litigation.” Health Serv. Outcomes Res. Methodol.2 (2001): 169-88.
124. Angrist, J. D., Imbens, G. W., and Rubin, D. B. “Identifi cation of causal eff ects using instrumental variables.” J. Am. Stat. Assoc.91 (1996): 444-54;
125. Newhouse, J. P. and McClellan, M. “Econometrics in outcomes research: The use of instrumental variables.” Annu. Rev. Public Health19 (1998): 17-34.
126. Hernan, M. A. and Robins, J. M. “Instruments for causal inference: An epidemiologist's dream?” Epidemiology17 (2006): 360-72
127. Greenland, S. “An introduction to instrumental variables for epidemiologists.” Int. J. Epidemiol.29 (2000): 722-9.
128. Posner, M. A., Ash, A. S., Freund, K. M., Moskowitz, M. A., and Schwartz, M. “Comparing standard regression, propensity score matching, and instrumental variables for determining the infl uence of mammography on stage of diagnosis.” Health Serv. Outcomes Res. Methodol.2 (2001): 279-90.
129. Newhouse, J. P. and McClellan, M. “Econometrics in outcomes research: The use of instrumental variables.” Annu. Rev. Public Health19 (1998): 17-34.
130. Staiger, D. and Stock, J. H. “Instrumental variables regression with weak instruments.” Econometrica 63 (1997): 557-86
131. Posner, M. A., Ash, A. S., Freund, K. M., Moskowitz, M. A., and Schwartz, M. “Comparing standard regression, propensity score matching, and instrumental variables for determining the infl uence of mammography on stage of diagnosis.” Health Serv. Outcomes Res. Methodol.2 (2001): 279-90.
132. Angrist, J. D., Imbens, G. W., and Rubin, D. B. “Identifi cation of causal eff ects using instrumental variables.” J. Am. Stat. Assoc.91 (1996): 444-54.
133. Fortney, J. C., Steffi ck, D. E., Burgess, J. F., Maciejewski, M. L., and Petersen, L. A. “Are primary care services a substitute or complement for specialty and inpatient services?” Health Serv. Res.40 (2005): 1422-42.
134. Harris, K. M. and Remler, D. K. “Who is the marginal patient? Understanding instrumental variables estimates of treatment eff ects.” Health Serv. Res.33 (1998): 1337-60.
135. Imbens, G. W. and Angrist, J. D. “Identifi cation and estimation of local average treatment eff ects.” Econometrica62 (1994): 467-75.
136. D’Agostino, R. B. Jr. and D’Agostino, R.B. Sr. “Estimating treatment eff ects using observational data.” JAMA 297 (2007): 314-16
137. D’Agostino, R. B. Jr. and D’Agostino, R. B. Sr. “Using observational data to estimate treatment eff ects - Reply.” JAMA 297 (2007): 2079.
138. Schwarcz, S K., Hsu, L. C., Vittinghoff, E., Vu, A., Bamberger, J. D., and Katz, M. H. “Impact of housing on the survival of persons with AIDS.” BMC Public Health 9 (2009): 220.
139. Shadish, W. R., Cook, T. D., and Campbell, D. T. Experimental and Quasi-experimental Designs for Generalized Causal Inference. Boston: Houghton Miffl in, 2002: pp. 171-206.
140. Zetola, N. M., Grijalva, C. G., Gertler, S., et al. “Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-2007.” PloS One 3 (2008): e2591.
141. Wagner, A. K., Soumerai, S. B., Zhang, F., and Ross-Degnan, D. “Segmented regression analysis of interrupted time series studies in medication use research.” J. Clin. Pharm. Ther.27 (2000): 299-309.
142. Hartmann, D. P., Gottman, J. M., Jones, R. R., et al. “Interrupted timesseries analysis and its application to behavioral data.” J. Applied Behav. Anal. 13 (1980): 543-59
143. Garson, C.D. Time Series Analysis, 2008. http://faculty.chass.ncsu.edu/garson/PA765/time.htm
144. Cochrane Eff ective Practice and Organisation of Care Group. “EPOC methods paper: Includinginterrupted time series (ITS) designs in a EPOC review.” 1998. http://epoc.cochrane.org/Files/Website/Reviewer%20Resources/inttime.pdf.
145. Shadish, W. R., Cook, T. D., and Campbell, D. T. Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Boston: Houghton Miffl in, 2002: p. 174.
146. Cochrane Effective Practice and Organisation of Care Group. “EPOC methods paper: Includinginterrupted time series (ITS) designs in a EPOC review.” 1998. http://epoc.cochrane.org/Files/Website/Reviewer%20Resources/inttime.pdf
147. England, E. “How interrupted time series analysis can evaluate guideline implementation.” Pharm. J. 275 (2005): 344-7
148. Hartmann, D. P., Gottman, J. M., Jones, R. R., et al. “Interrupted times-series analysis and its application to behavioral data.”J. Applied Behav. Anal. 13 (1980): 543-59.
149. De Martino, M., Tovo, P.-A., Balducci, M., et al. “Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection.” JAMA 284 (2000): 190-7.
150. Piaggio, G., Elbourne, D. R., Altman, D. G., et al.“Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement.” JAMA 295 (2006): 1152-60.
151. Kaul, S. and Diamond, G. A. “Good enough: A primer on the analysis and interpretation of noninferiority trials.”Ann. Intern. Med. 145 (2006): 62-9
152. Gotzsche, P. C. “Lessons from and cautions about noninferiority and equivalence randomized trials.” JAMA295 (2006): 1172-4.
153. Djulbegovic, B. and Clarke, M.“Scientifi c and ethical issues in equivalence trials.” JAMA 285 (2001): 1206-8.
154. Puhan, M. A., Busching, G., Schunemann, H. J., van Oort, E., Zaugg, C., and Frey, M. “Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease.” Ann. Intern.Med.145 (2006): 816-25.
155. Parienti, J. J., Th ibon, P., and Heller, R., “Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study.” JAMA288 (2002): 722-7.
156. Morey, M. C., Snyder, D. C., Sloane, R., et al. “Eff ects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors.” JAMA 301 (2009): 1883-91.
157. Rothman, K. J. “No adjustments are needed for multiple comparisons.” Epidemiology1 (1990): 43-6.
158. Lallermant, M., Jourdain, G., Le Coeur, S., et al. “Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.” N. Engl. J. Med. 351 (2004): 217-28.
159. Montori, V. M., Devereaux, P. J., Adhikari, N. K. J., et al. “Randomized trials stopped early for benefit.” JAMA294 (2005): 2203-9.
160. Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., and Drazen, J. M. “Statistics in medicine - reporting of subgroup analyses in clinical trials.” N. Engl. J. Med.357 (2007): 2189-94.
161. Heitjan, D. F. “What can be done about missing data? Approaches to imputation.” Am. J. Public Health87 (1997): 548-50
162. Rubin, D. B. Multiple Imputation for Nonresponse in Surveys. New York: Wiley, 1987.
163. Katz, M. H. Multivariable Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge University Press, 2006: pp. 87-94.
164. Streiner, D. L. “The case of the missing data: Methods of dealing with dropouts and other research vagaries.” Can. J. Psychiatry47 (2002): 68-75
165. Molnar, F. J., Hutton, B., and Fergusson, D. “Does analysis using ‘last observation carried forward’ introduce bias in dementia research?” CMAJ 179(2008). www.cmaj.ca/cgi/content/full/179/8/751
166. Katz, M. H. Multivariable Analysis: A Practical Guide for Clinicians. Cambridge: Cambridge University Press, 2006: pp. 164-71.
167. Moher, D., Shulz, K. F., and Altman, D., for the CONSORT group. “The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials.” JAMA 285 (2001): 1887-91.
168. Piaggio, G., Elbourne, D. R., Altman, D. G., Pocock, S. J., and Evans S. J. W., for the CONSORT Group. “Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement.” JAMA 295 (2006): 1152-60.
169. Des Jarlais, D. C., Lyles, C., Crepaz, N “Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: The Trend statement.” Am. J. Public Health 94 (2004): 361-6
170. Von Elm, E., Altman, D. G., Egger, M., et al. “The strengthening of the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies.” J. Clin. Epidemiol. 61 (2008): 344-9.
171. Moher, D., Schulz, K. F., Altman, D., for the CONSORT Group. “The CONSORT statement: revised recommendations for improving the quality of reports of parallel group trials. JAM A (2001) 285: 1987-91.
172. Lautenschlager, N. T., Cox, K. L., Flicker, et al. “Effect of physical activity or cognitive function in older adults at risk for Alzheimer disease.” JAMA300 (2008): 1027-37.
173. Marx, R., Hirozawa, A. M., Chu, P. L., Bolan, G. A., and Katz, M. H. “Linking clients from HIV antibody counseling and testing to prevention services.” J. Community Health24 (1999): 201-13.
174. Marx, R., Sebesta, D. S., Hirozawa, A. M., e t al., “Can follow-through on HIV prevention referrals be increased among high-risk seronegative individuals? An exploratory study”; unpublished paper.
175. Katz, M. H. “Banning tobacco sales in pharmacies: The right prescription.” JAMA300 (2008): 1451-3.
176. Katz, M. H. “Golden Gate to health care for all? San Francisco's new universal-access program.” N. Engl. J. Med.358 (2008): 327-9.
177. G lasgow, R. E., Vogt, T. M., and Boles, S. M. “Evaluating the public health impact of health promotion interventions: the RE-AIM framework.” Am. J. Public Health89 (1999): 1322-7.
178. Li, R., Harmer, P., and Glasgow, R., et al. “Translation of an eff ective Tai Chi intervention into a community-based falls-prevention program.” Am. J. Public Health 98 (2008): 1195-8.